# Antibiotics: Overview

Source page: https://www.materialinsights.org/technologies/antibiotics/tech-overview/

#### What it does

The job the technology does for people, in a short paragraph

Antibiotics cure infections caused by bacteria, such as pneumonia, blood poisoning and infected wounds, which often killed before the 1940s. Penicillin, the first, became a working drug in 1941 and 1942 ^[1, 2]. Antibiotics also protect patients during surgery and cancer treatment. Human use reached about 14.3 daily doses per 1,000 people per day in 2018 ^[5].

as of 2026-11-10

#### How it works

The working principle in plain words, step by step

Bacteria are single cells that differ from our own in key ways: many have a tough outer wall, and they build proteins with different machinery. An antibiotic is a molecule that attacks one of those differences. Penicillin, for example, stops bacteria from finishing their cell walls, so growing cells burst. Human cells have no such wall: Fleming found that even sensitive white blood cells were not harmed by penicillin ^[1]. Other families block bacterial protein making or copying of DNA. The drug is swallowed or injected and carried by the blood to the infection. It kills bacteria or stops them multiplying long enough for the immune system to clear them. Bacteria that survive by chance can pass on resistance, which is why misuse wears antibiotics out.

as of 2026-11-10

#### Key figures

The handful of numbers that size it up, each with its unit, year and source

| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| Human antibiotic use, world average | 14.3 | daily doses per 1,000 people per day | 2018 | ^[5] |
| Rise in human antibiotic use per person since 2000 | 46 | % | 2018 | ^[5] |
| Deaths caused directly by antibiotic-resistant bacteria | 1.27 | million deaths | 2019 | ^[4] |
| Deaths associated with antibiotic resistance | 4.95 | million deaths | 2019 | ^[4] |
| China's share of US antibiotic ingredient (API) imports, by volume | 70.1 | % | 2024 | ^[6] |

as of 2026-11-10. Antibiotic use is in defined daily doses, a standard measure of drug use. The resistance figures are from the Global Research on Antimicrobial Resistance study reported by Oxford [4]; the import share is from a Johns Hopkins study of US customs data reported by CIDRAP [6].

#### Where it is used

The main places and products the technology is found in

- Treating bacterial pneumonia, urinary, skin and blood infections
- Preventing infection during surgery, childbirth and cancer chemotherapy
- Treating tuberculosis and sexually transmitted infections
- Veterinary medicine and livestock farming

as of 2026-11-10

#### Scale today

How much of it there is now: units in use, made each year and who uses it

**Users**
: About 14.3 defined daily doses per 1,000 people per day worldwide ^[5]

**Unit**
: defined daily doses

**Year**
: 2018

**Note**
: Human use only; a defined daily dose is the typical adult dose for one day.

as of 2026-11-10

#### Sources

1. [Physiology or Medicine 1945: Presentation Speech](https://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/press.html) Nobel Prize Outreach (nobelprize.org)
2. [From Penicillin to Phages: Yale's Century-Long Fight Against Infection](https://medicine.yale.edu/news-article/from-penicillin-to-phages-yales-century-long-fight-against-infection/) Yale School of Medicine, 2026
3. [An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections](https://www.ox.ac.uk/news/2022-01-20-estimated-12-million-people-died-2019-antibiotic-resistant-bacterial-infections) University of Oxford
4. [Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study](https://doaj.org/article/07180a811c5d4f6380ed7ff503c5082b) The Lancet Planetary Health, on DOAJ, 2021
5. [US relies heavily on China, other nations for antibiotics](https://www.cidrap.umn.edu/resilient-drug-supply/us-relies-heavily-china-other-nations-antibiotics) CIDRAP, University of Minnesota (reporting a Johns Hopkins study in JAMA Health Forum)

## Other sections

- [Summary](https://www.materialinsights.org/technologies/antibiotics/index.md)
- [Science](https://www.materialinsights.org/technologies/antibiotics/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/antibiotics/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/antibiotics/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/antibiotics/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/antibiotics/tech-industries/index.md)
